Sonya F. Erickson is a partner in Cooley's Emerging Companies and Life Sciences practice groups and a member of the Firm's Business department. She joined the Firm in 2008 and is resident in the Seattle office.
Ms. Erickson's practice encompasses the representation of emerging growth companies, established technology businesses and venture capital funds.
Ms. Erickson has represented issuers and underwriters in numerous public offerings, has substantial experience in venture capital and other private financing transactions and has worked on technology-based strategic partnerships, collaborations and mergers and acquisitions. In addition, Ms. Erickson is corporate counsel for numerous private and public companies including Alder Biopharmaceuticals, Inc., ARZEDA Corporation, Blue Nile, Inc. (NILE), EKOS Corporation, EndoGastric Solutions, Inc., Ground Truth, Inc., Seattle Genetics, Inc. (SGEN), Varolii Corporation, and Zumobi, Inc.
Ms. Erickson has represented these and numerous other clients from incorporation through initial public offering, merger and beyond. She regularly advises boards of directors and audit committees with respect to the requirements of Sarbanes-Oxley and the development and implementation of best practices in corporate governance.
Prior to joining Cooley, Ms. Erickson was a shareholder at Heller Ehrman and a director and one of the founding members of the Seattle office of Venture Law Group before the merger with Heller Ehrman. While at Heller and Venture Law Group, she represented the issuers and underwriters in several public offerings including IDEC Pharmaceuticals, SanDisk Corporation, HomeGrocer.com, Seattle Genetics, Inc., Xcyte Therapies, Inc., Celebrate Express, Inc., Goldman Sachs and Deutsche Bank Securities. She was also involved in many complex deals and transactions, including the sale of companies to Baxter International, Elbit, Ltd., Microsoft, 3M, Research in Motion (Blackberry), Siemens and most recently the sale of Qpass, Inc. to Amdocs Limited in May 2006, the merger of Ikaria with INO Therapeutics, Inc. in March, 2007, the sale of Free & Clear, Inc. to Inverness Medical Innovations, Inc. in September, 2009, and the sale of Sabrix, Inc. to Thomson Reuters in December, 2009.
Prior to joining Venture Law Group, Ms. Erickson was an associate in the Los Angeles office of Jones Day and the Palo Alto office of Brobeck Phleger & Harrison.
Ms. Erickson earned her JD from the University of Washington School of Law after graduating with honors with a BS in Business and Economics from Pepperdine University.
Ms. Erickson is admitted to practice in Washington State and California and is a member of the Washington State Bar Association.
- University of Washington School of Law
- Pepperdine University
BS Business and Economics, 1987, With honors
- Washington State Bar Association